Results 161 to 170 of about 3,721,297 (234)

GLP‐1 Receptor Agonists and Weight Loss: A Critical Review of Mechanisms

Obesity Reviews, Volume 27, Issue 11, November 2026.
ABSTRACT GLP‐1 receptor agonist medications have the potential to promote marked weight loss, but maximal and sustained benefit may be compromised by poor compliance and cessation of use. Development of next‐generation medications that address current obstacles to effective use and development of effective adjunct treatments will benefit from better ...
Giorgia Rutigliani, Tzu‐Wen L. Cross, Erica de Jong, Emily S. Glover, Ivan D. Mendoza, Mojisola Adisa, Keigo Tomoo, Xinyi Zhou, Richard D. Mattes   +8 more
wiley   +1 more source

Psychoactive drug use and substance-induced psychosis: Emerging challenges in a low-middle-income country. [PDF]

Ther Adv Psychopharmacol
Pathak N, Shrestha S.
europepmc   +1 more source

The Lupus Damage Index Revision Program: Results From the Item Generation and Reduction Phases

Arthritis Care &Research, Volume 78, Issue 10, Page 1449-1466, October 2026.
Objective A data‐driven and expert/patient consensus‐based project to develop a revised Systemic Lupus International Collaborating Clinics (SLICC)/American College of Rheumatology (ACR) Damage Index (SDI) is under way supported by SLICC, ACR, and the Lupus Foundation of America. Our objective is to report the item generation and reduction phase results
Burak Kundakci, Megan R. W. Barber, Ann E. Clarke, Sindhu R. Johnson, Anselm Mak, Hermine I. Brunner, Murat Inanc, Rosalind Ramsey‐Goldman, Guillermo Ruiz‐Irastorza, Ellen M. Ginzler, John G. Hanly, Alexandra Legge, Cynthia Aranow, Laurent Arnaud, Nathalie Costedoat‐Chalumeau, Dafna D. Gladman, Søren Jacobsen, Michelle Petri, Clovis A. Silva, Évelyne Vinet, Alexandre E. Voskuyl, SDI Revision Literature Review Groups, SDI Revision Delphi Panel, SDI Revision Item Reduction Committee, SDI Revision Clinical Domain Groups, Ian N. Bruce   +25 more
wiley   +1 more source

Substance Use and Incidence of Psychosis Diagnoses Among Gay, Bisexual, and Other Men Who Have Sex with Men Compared with Males from the General Population: A Matched Cohort Study from Metro Vancouver, Canada. [PDF]

Subst Use Misuse
Gormezano A, Adams A, Wang L, Trigg J, Budu M, Hogg RS, Aguilera-Mijares S, Hull M, Barath J, Sereda P, Lal A, Cox J, Hart TA, Grace D, Tan DHS, Lachowsky NJ, Moore DM.   +16 more
europepmc   +1 more source

Cortisol Dynamics at High Temporal Resolution For Wearable Biosensor Research

Advanced Sensor Research, Volume 5, Issue 10, October 2026.
High‐frequency cortisol profiling reveals that endocrine responses depend strongly on both stressor type and the individual. Circadian sampling shows a consistent morning‐to‐evening decline, while cold exposure elicits delayed rises and exercise and cognitive challenges produce divergent trajectories.
Munia Ferdoushi, Tess Billings, Wenxin Cai, Yasser Khan   +3 more
wiley   +1 more source

Comorbid Mood and Anxiety Disorder Diagnoses in Patients With First-Episode Psychosis: Comparison Between Research and Clinical Diagnoses. [PDF]

Early Interv Psychiatry
Walta M, Laurikainen H, Armio RL, From T, Vahlberg T, Tolvanen A, Salokangas RKR, Hietala J.   +7 more
europepmc   +1 more source

Distinct Neuropsychiatric Profiles Associated With 17p11.2 Deletions and RAI1 Variants in Smith–Magenis Syndrome

American Journal of Medical Genetics Part A, Volume 200, Issue 10, Page 2320-2330, October 2026.
ABSTRACT Smith–Magenis syndrome (SMS) results from either a recurrent 17p11.2 deletion or pathogenic variants in the retinoic acid induced 1 gene (RAI1). While neurodevelopmental impairment and behavioral dysregulation are well recognized, systematic genotype‐stratified analyses across psychiatric domains remain limited.
Albin Blanc, Christophe Nemos, Céline Bonnet, Mathilde Renaud, Sandra Chapuis, Pauline Boiroux, Marie‐Noëlle Babinet, Caroline Demily   +7 more
wiley   +1 more source

Exploring Associations Between Hypoxia, Serum Erythropoietin, and Cognition in Patients With Mood Disorders and Healthy Individuals

Brain and Behavior, Volume 16, Issue 10, October 2026.
ABSTRACT Purpose Moderate repeated hypoxia (MRH) has shown neuroprotective and neuroplastic effects, partly mediated by erythropoietin (EPO) via hypoxia‐inducible factors (HIFs). This study examined the effects of 3 weeks of daily 3.5‐h normobaric hypoxia (12% O2) versus normoxia (20% O2) combined with cognitive training on oxygen saturation (SpO2 ...
Barbara Emilie Rotbøl Ørum, Johanna Mariegaard Schandorff, Viktoria Damgaard, Eya‐Mist Rødgaard, Caroline Fussing Bruun, Morten Meyer, Lars Vedel Kessing, Martin Balslev Jørgensen, Kamilla Woznica Miskowiak   +8 more
wiley   +1 more source